The trial will examine the efficacy, safety, and pharmacodynamics of S-606001 SRT used with ERT in confirmed LOPD adults.

Rhythm Pharmaceuticals (RYTM) stock gains as FDA OKs a label expansion for the company's lead asset, Imcivree, to treat acquired hypothalamic obesity. Read more here.

Drug stocks can be somewhat volatile. Things like clinical setbacks or patent cliffs can sink their stock prices or erode ...

Ozempic personality is a psychological impact of using Ozempic for weight loss. You need to know the possible side effects on your mental health to be careful.

An analysis of 2.2 million people reveals both shared and substance-specific genetic pathways for addiction risk, showing ...

Collateral Damage, a new podcast at The Intercept hosted by criminal justice reporter Radley Balko, examines "the half-century-long war on drugs, its enduring ripple effects, and the devastating ...

A Colorado police officer suffered a serious head injury in a violent struggle with an accused drug dealer, but the suspect ...

At the time of his arrest, he was allegedly found with fentanyl, cocaine, oxycodone, a 9mm semiautomatic pistol with an extended magazine and a “Glock switch.” ...

Abivax and Nektar Therapeutics are clinical-stage biotech companies that would make attractive buyout targets.

A Connecticut senator is advocating for a bill to establish overdose prevention centers in the state, which he said prevent drug overdoses and save lives.

The U.S. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’  therapy for a rare form of obesity ​caused ...

Swiss drugmaker Novartis on Friday agreed to buy a breast cancer drug candidate for up to $3 billion from U.S. biotech firm ...